Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: Results of the Tokyo Children's Cancer Study Group Study L99-15

British Journal of Haematology

Volumn 156, Issue 3, 2012, Pages 358-365

  Inukai, Takeshi ^a   Kiyokawa, Nobutaka ^b   Campana, Dario ^c,d   Coustan Smith, Elaine ^c,d   Kikuchi, Akira ^e   Kobayashi, Miyuki ^f   Takahashi, Hiroyuki ^g   Koh, Katsuyoshi ^e   Manabe, Atsushi ^h   Kumagai, Masaaki ⁱ   Ikuta, Koichiro ^j   Hayashi, Yasuhide ^k   Tsuchida, Masahiro ^l   Sugita, Kanji ^a   Ohara, Akira ^m  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g Saiseikai Yokohama City Nanbu Hospital   (Japan)

^h ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

ⁱ NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^j YOKOHAMA CITY UNIVERSITY   (Japan)

^k Department of Hematology/Oncology   (Japan)

^l Ibaraki Children's Hospital   (Japan)

^m TOHO UNIVERSITY   (Japan)

more..

Author keywords

Acute lymphoblastic leukaemia; Allogeneic stem cell transplantation; Cell marker profile; Childhood; Early T cell precursor

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; DRUG MEGADOSE; DRUG RESPONSE; EARLY T CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA; EVENT FREE SURVIVAL; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; JAPAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84855793253     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08955.x     Document Type: Article

References (18)

1. Attarbaschi, A., Pisecker, M., Inthal, A., Mann, G., Janousek, D., Dworzak, M., Pötschger, U., Ullmann, R., Schrappe, M., Gadner, H., Haas, O.A., Panzer-Grümayer, R. & Strehl, S.; Austrian Berlin-Frankfurt-Münster (BFM) Study Group (2010) Prognostic relevance of TLX3 (HOX11L2) expression in childhood T-cell acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing early and late re-intensification elements. British Journal of Haematology, 148, 293-300.
2. Bell, J.J. & Bhandoola, A. (2008) The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature, 452, 764-767.
3. Cleaver, A.L., Beesley, A.H., Firth, M.J., Sturges, N.C., O'Leary, R.A., Hunger, S.P., Baker, D.L. & Kees, U.R. (2010) Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study. Molecular Cancer, 9, 105-116.
4. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., Biondi, A., Pui, C.H., Downing, J.R. & Campana, D. (2009) Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncology, 10, 147-155.
5. Dalmazzo, L.F., Jácomo, R.H., Marinato, A.F., Figueiredo-Pontes, L.L., Cunha, R.L., Garcia, A.B., Rego, E.M. & Falcão, R.P. (2009) The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment. British Journal of Haematology, 144, 223-229.
6. Goldberg, J.M., Silverman, L.B., Levy, D.E., Dalton, V.K., Gelber, R.D., Lehmann, L., Cohen, H.J., Sallan, S.E. & Asselin, B.L. (2003) Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. Journal of Clinical Oncology, 21, 3616-3622.
7. Gottardo, N.G., Hoffmann, K., Beesley, A.H., Freitas, J.R., Firth, M.J., Perera, K.U., de Klerk, N.H., Baker, D.L. & Kees, U.R. (2007) Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia. British Journal of Haematology, 137, 319-328.
8. Karrman, K., Forestier, E., Heyman, M., Andersen, M.K., Autio, K., Blennow, E., Borgström, G., Ehrencrona, H., Golovleva, I., Heim, S., Heinonen, K., Hovland, R., Johannsson, J.H., Kerndrup, G., Nordgren, A., Palmqvist, L. & Johansson, B.; Nordic Society of Pediatric Hematology, Oncology (NOPHO); Swedish Cytogenetic Leukemia Study Group (SCLSG); NOPHO Leukemia Cytogenetic Study Group (NLCSG). (2009) Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome. Genes Chromosomes Cancer, 48, 795-805.
9. Manabe, A., Ohara, A., Hasegawa, D., Koh, K., Saito, T., Kiyokawa, N., Kikuchi, A., Takahashi, H., Ikuta, K., Hayashi, Y., Hanada, R. & Tsuchida, M.; Tokyo Children's Cancer Study Group. (2008) Significance of the complete clearance of peripheral blasts after 7days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15. Haematologica, 93, 1155-1160.
10. Pui, C.H. & Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166-178.
11. Pui, C.H., Robison, L.L. & Look, A.T. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 1030-1043.
12. Pui, C.H., Campana, D., Pei, D., Bowman, W.P., Sandlund, J.T., Kaste, S.C., Ribeiro, R.C., Rubnitz, J.E., Raimondi, S.C., Onciu, M., Coustan-Smith, E., Kun, L.E., Jeha, S., Cheng, C., Howard, S.C., Simmons, V., Bayles, A., Metzger, M.L., Boyett, J.M., Leung, W., Handgretinger, R., Downing, J.R., Evans, W.E. & Relling, M.V. (2009) Treating childhood acute lymphoblastic leukemia without cranial irradiation. New England Journal of Medicine, 360, 2730-2741.
13. Pullen, J., Shuster, J.J., Link, M., Borowitz, M., Amylon, M., Carroll, A.J., Land, V., Look, A.T., McIntyre, B. & Camitta, B. (1999) Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia, 13, 1696-1707.
14. Schneider, N.R., Carroll, A.J., Shuster, J.J., Pullen, D.J., Link, M.P., Borowitz, M.J., Camitta, B.M., Katz, J.A. & Amylon, M.D. (2000) New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood, 96, 2543-2549.
15. Schrauder, A., Reiter, A., Gadner, H., Niethammer, D., Klingebiel, T., Kremens, B., Peters, C., Ebell, W., Zimmermann, M., Niggli, F., Ludwig, W.D., Riehm, H., Welte, K. & Schrappe, M. (2006) Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. Journal of Clinical Oncology, 24, 5742-5749.
16. Weng, A.P., Ferrando, A.A., Lee, W., Morris, J.P. IV, Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. & Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science, 306, 269-271.
17. Winter, S.S., Jiang, Z., Khawaja, H.M., Griffin, T., Devidas, M., Asselin, B.L. & Larson, R.S. (2007) Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood, 110, 1429-1438.
18. Zuurbier, L., Homminga, I., Calvert, V., te Winkel, M.L., Buijs-Gladdines, J.G., Kooi, C., Smits, W.K., Sonneveld, E., Veerman, A.J., Kamps, W.A., Horstmann, M., Petricoin, III, E.F., Pieters, R. & Meijerink, J.P. (2010) NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia, 24, 2014-2022.